Clay Siegal the CEO of Seattle Genetics.

Clay B. Siegall co-founded Seattle Genetics in the year 1998 and he is the organization’s President, Chairman of the Board and C.E.O. HE IS A PROFESSIONAL scientist with target OF cancer therapies. Dr. Clay B.Siegall established Seattle Genetics for a scientific innovation, drug development practices, and thorough research in addition, h has a passion for helping all patients in need of him. He has led the company to its present leadership spot in getting the 2011 FDA approval of its first ADC product ADCETRIS® (brentuximab vedotin) together with making antibody-drug conjugates. Under collaboration with a company known as Takeda Pharmaceutical Company, ADCETRIS is now an international brand that is used in approximately more than 65 nations.

Under Dr. Siegall’s guardianship and leadership, Seattle Genetics has got in into many important licenses for its ADC technology, for example, AbbVie, Genentech (Roche), Pfizer and also GlaxoSmithKlin, that has brought about more than $350 million currently. Across local and collaborator programs, there are approximately more than 20 ADCs in clinical establishment using Seattle Genetics’ technology programme. Dr. Siegall has also guided and led Seattle Genetics’ capital-raising activities, which secured more than $1.2 billion through private and public financings.

Before co-founding Seattle Genetics, Dr. Siegall was with Bristol-Myers Squibb Pharmaceutical Research Institute from the year 1991 to 1997 together with the National Institutes of Health and the National Cancer Institute from 1988 to 1991. He worked on the Boards of Directors of Washington Roundtable, Alder Biopharmaceuticals, and Ultragenyx Pharmaceutical. Dr. Siegall has received of a number of awards, like the Math and Natural Sciences, the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year and the 2013 University of Maryland Alumnus of the Year for Computer. Furthermore, he is an author of not less than 70 publications and has 15 patents. He graduated with a Ph.D. in Genetics from the prestigious George Washington University, together with a B.S. in Zoology from the famous University of Maryland.